After Hours Gainers:
Companies trading higher in after hours in reaction to guidance: AVID +10.6%
Companies trading higher in after hours in reaction to news: FLNT +21.1% (authorizes the repurchase of up to $5 mln shares of common stock), BCRX +9.6% (Point72 increases passive stake), STNG +4.4% (announced its President purchased call options), CTMX +3.7% (initiated with a Buy at Guggenheim), ENDP +3.1% (announces FDA acceptance of BLA for collagenase clostridium histolyticum in patients with cellulite), MYOV +2.9% (continued strength), SLB +0.3% (initiated with a Buy at Deutsche Bank)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: URBN -14%, ALC -1.7%
Companies trading lower in after hours in reaction to news: ORGO -8.9% (to sell 9 mln shares of its Class A common stock in an underwritten public offering), CRSP -4.9% (announces public offering of 4.25 mln common shares), AMRN -3.6% (initiated with Underperform at Oppenheimer; tgt $7), AEO -3.5% (following URBN results), MGP -3% (commences public offering of 24.0 mln Class A shares), NYMT -2.7% (announces public offering of 25 mln shares of common stock), MAC -2.6% / SPG -0.9% (Carl Icahn touted as likely largest short-seller of mall debt in Wall Street Journal report), MSEX -2.1% (proposes public offering of ~$35 mln of shares of common stock), RIG -2.1% (initiated with a Sell at Deutsche Bank), MTZ -1.9% (attributed to block trade pricing), QTT -1% (files for $80 mln Class A Ordinary Share offering)
In reaction to disappointing earnings/guidance:
- KSS -11.8%, WWD -6.1%, HD -4.5%, ASH -3.4%, ZTO -2.6%, ARMK -1%, TDG -0.5%
Other news:
- KRTX -10.3% (files for 2.6 mln share common stock offering)
- DHT -5.6% (DHT announces that BW Group has begun an offering of 14.68 mln shares )
- M -5.1% (in sympathy with KSS)
- GSX -4.5% (files for offering of 15 mln ADS representing 10 mln Class A ordinary shares by selling shareholders), I -3.7% (continued weakness; also downgraded to In-line from Outperform at Evercore ISI)
- PFGC -3.2% (commenced a public offering of an aggregate of 9,200,000 shares of its common stock on a forward sale basis)
- EGHT -3% ( files for $75 mln shelf offering of 0.50% Convertible Senior Notes due 2024 )
- EFC -2.7% (commences public offering of 4.2 mln shares of common stock)
- LOW -2% (in sympathy with HD)
- DUK -1.3% (prices offering of 25 mln shares of common stock at $86.45 per share in connection with the forward sale agreement)
- ROKU -1.2% (files for 571,459 share Class A common stock offering by holders)
- SPCE -0.9% (files for offering of 30,999,976 shares of common stock underlying warrants)
- TGT -0.9% (in sympathy with KSS)
- WMT -0.4% (in sympathy with HD)
Analyst comments:
- MSGN -5.3% (downgraded to Sell from Neutral at Guggenheim)
- BLUE -2.6% (downgraded to In-line from Outperform at Evercore ISI)
- T -1.3% (downgraded to Sell from Neutral at MoffettNathanson)
- LEG -1.1% (downgraded to Hold from Buy at Stifel)
Gapping up
In reaction to strong earnings/guidance:
- CRMT +10.2%, JKS +5.8%, BILI +4.8%, WUBA +4%, MDT +1.9%, ASND +0.9%
M&A news:
- MDCO +28.4% (reports the company is fielding takeover interest from several parties)
- DIOD +4.4% (pending acquisition of Lite-On Semiconductor said to be scrutinized by Chinese regulators, according to Bloomberg)
Other news:
- MYOV +51.8% (Phase 3 HERO study of once-daily, oral relugolix (120 mg) met its primary efficacy endpoint)
- NOW +4.1% (to join S&P 500, effective prior to the open on November 21)
- ACHN +2.2% (EMA has granted access to support through the PRIME program for danicopan)
- CLVS +2.1% (continued strength)
- ADS +2.1% (announces Ralph Andretta as new CEO and President, effective February 3, 2020)
- AMC +1.9% (extending late move higher after the WSJ reported that the DOJ will kill the Paramount consent decree which prevented studios form owning exhbitors)
- CNK +0.9% (extending late move higher after the WSJ reported that the DOJ will kill the Paramount consent decree which prevented studios form owning exhbitors)
- TMO +0.7% (to join S&P 100)
Analyst comments:
- BOLD +2.7% (upgraded to Outperform from In-line at Evercore ISI)
- OKTA +2.4% (upgraded to Buy at DA Davidson)
- SPLK +1.4% (initiated with a Buy at DA Davidson)
- GBDC +0.7% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)